Engineering Novel Targeted Muscle Delivery Technologies to Enhance Oligonucleotide Delivery & Biodistribution
2:00 pm - Wednesday 27th January 2027
- Moving towards delivery platforms that enhance payload delivery to increase efficient drug delivery
- Addressing poor specificity and the consequences of long-term drug accumulation
- Exploring how we can achieve more accurate delivery and trafficking characteristics to the muscle for DM1 therapies
